Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.03 USD | +1.82% | -0.24% | +18.48% |
02/05 | Wedbush Raises SpringWorks Therapeutics' Price Target to $75 From $70, Keeps Outperform Rating | MT |
02/05 | SpringWorks Therapeutics Shares Fall After Wider-Than-Expected Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.48% | 3.13B | |
+3.23% | 108B | |
+10.30% | 105B | |
+1.57% | 23.46B | |
-12.92% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.19% | 17.19B | |
+5.94% | 13.99B | |
+36.84% | 12.53B |
- Stock Market
- Equities
- SWTX Stock
- News SpringWorks Therapeutics, Inc.
- Wedbush Raises SpringWorks Therapeutics' PT to $70 From $60, Increases Sales Estimates for Ogsiveo, Mirdametinib; Keeps Outperform Rating